María Ortiz

Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Blood · 2018 · 495 citations · Full text

Medicine, Molecular Biology, Oncology +12

A high-risk, Double-Hit, group of newly diagnosed myeloma identified by genomic analysis

Brian A. Walker, Konstantinos Mavrommatis, Christopher P. Wardell et al. · Leukemia · 2018 · 453 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Changes in blood microbiota profiles associated with liver fibrosis in obese patients: A pilot analysis

Benjamin Lelouvier, Florence Servant, Sandrine Païssé et al. · Hepatology · 2016 · 242 citations · Full text

Life Sciences, Microbiology, Medical Microbiology +16

Iberdomide (CC-220) is a potent cereblon E3 ligase modulator with antitumor and immunostimulatory activities in lenalidomide- and pomalidomide-resistant multiple myeloma cells with dysregulated CRBN

Chad C. Bjorklund, Jian Kang, Michael Amatangelo et al. · Leukemia · 2019 · 196 citations · Full text

Medicine, Oncology, Pharmacology +15

High subclonal fraction of 17p deletion is associated with poor prognosis in multiple myeloma

Anjan Thakurta, María Ortiz, Pedro Blecua et al. · Blood · 2019 · 113 citations · Full text

Medicine, Molecular Genetics, Oncology +13